DEVICE Act of 2023 Disclosure; and Encouragement of Verification, Innovation, Cleaning, and Efficiency Act of 2023
Impact
The impact of HB 1090 is significant as it aims to improve the oversight of medical device manufacturers, making it mandatory for them to report design modifications and reprocessing protocols. This measure is thought to enhance patient safety, as devices that are inadequately maintained or improperly altered can pose serious health risks. The legislation represents a shift toward more stringent regulatory frameworks in the medical device sector, intended to foster innovation while also safeguarding public health.
Summary
House Bill 1090, known as the DEVICE Act of 2023, seeks to amend the Federal Food, Drug, and Cosmetic Act to enhance the communication regarding medical devices and ensure their cleanliness. The bill introduces reporting requirements for manufacturers regarding design changes and reprocessing instructions of medical devices marketed in interstate commerce. It emphasizes transparency and accountability, mandating manufacturers to notify the Secretary of any changes before they are implemented, thereby aiming to elevate device safety standards.
Contention
Notably, some industry stakeholders may express concerns regarding the regulatory burden this bill places on manufacturers. Critics argue that the increased reporting requirements could stifle innovation and delay the introduction of new medical technologies. Supporters counter that such measures are essential to ensure that innovations do not compromise safety and efficacy, and that the bill includes provisions for rapidly assessing reprocessing of reusable devices to ensure they remain safe for patient use.